PDCD1 and neoplasm: This finding meant that an increase in the number of tumor-infiltrating lymphocytes (TILs) expressing PD-1 (as a co-inhibitory immune checkpoint) has occurred and neutralized the positive immune-stimulatory effects of the chemotherapy (88).